BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $226,855 | -17.2% | 6,011 | 0.0% | 0.02% | -14.3% |
| Q2 2023 | $273,861 | -36.1% | 6,011 | -43.1% | 0.02% | -40.0% |
| Q1 2023 | $428,354 | -36.1% | 10,561 | -19.7% | 0.04% | -44.4% |
| Q4 2022 | $670,357 | -15.5% | 13,152 | -10.7% | 0.06% | -14.9% |
| Q3 2022 | $793,000 | -43.8% | 14,726 | -33.0% | 0.07% | -40.3% |
| Q2 2022 | $1,411,000 | -17.9% | 21,968 | -0.9% | 0.12% | -0.8% |
| Q1 2022 | $1,719,000 | -10.9% | 22,168 | -1.3% | 0.12% | +0.8% |
| Q4 2021 | $1,929,000 | -17.8% | 22,468 | -23.0% | 0.12% | -27.5% |
| Q3 2021 | $2,348,000 | -32.5% | 29,187 | -32.4% | 0.17% | -29.9% |
| Q2 2021 | $3,477,000 | -0.7% | 43,202 | +4.1% | 0.24% | -10.0% |
| Q1 2021 | $3,500,000 | +4.6% | 41,502 | -0.4% | 0.27% | +15.3% |
| Q4 2020 | $3,345,000 | +0.5% | 41,682 | +0.7% | 0.24% | -10.0% |
| Q3 2020 | $3,329,000 | -2.3% | 41,392 | +4.6% | 0.26% | -12.7% |
| Q2 2020 | $3,406,000 | +13.1% | 39,562 | +6.7% | 0.30% | -12.6% |
| Q1 2020 | $3,011,000 | -4.4% | 37,087 | -1.5% | 0.34% | +17.1% |
| Q4 2019 | $3,149,000 | -4.4% | 37,662 | 0.0% | 0.29% | -12.3% |
| Q3 2019 | $3,294,000 | +6.4% | 37,662 | -0.4% | 0.33% | +2.8% |
| Q2 2019 | $3,097,000 | +0.7% | 37,812 | 0.0% | 0.32% | -2.4% |
| Q1 2019 | $3,074,000 | +23.5% | 37,812 | 0.0% | 0.33% | +7.1% |
| Q4 2018 | $2,489,000 | -15.3% | 37,812 | -0.9% | 0.31% | -1.3% |
| Q3 2018 | $2,940,000 | -4.3% | 38,137 | -8.3% | 0.31% | -11.8% |
| Q2 2018 | $3,072,000 | +14.1% | 41,605 | +0.5% | 0.36% | +8.5% |
| Q1 2018 | $2,692,000 | -0.6% | 41,389 | -1.2% | 0.33% | -0.3% |
| Q4 2017 | $2,709,000 | +3.0% | 41,904 | 0.0% | 0.33% | -4.1% |
| Q3 2017 | $2,629,000 | +3.6% | 41,904 | 0.0% | 0.34% | +0.6% |
| Q2 2017 | $2,537,000 | +16.8% | 41,904 | 0.0% | 0.34% | +11.8% |
| Q1 2017 | $2,173,000 | +17.0% | 41,904 | 0.0% | 0.30% | +7.8% |
| Q4 2016 | $1,858,000 | -6.9% | 41,904 | 0.0% | 0.28% | -5.7% |
| Q3 2016 | $1,995,000 | +2.4% | 41,904 | -2.8% | 0.30% | -3.8% |
| Q2 2016 | $1,949,000 | +3.1% | 43,104 | -6.3% | 0.31% | +3.7% |
| Q1 2016 | $1,890,000 | +3.7% | 46,004 | -3.7% | 0.30% | +1.3% |
| Q4 2015 | $1,823,000 | -3.0% | 47,779 | -16.5% | 0.30% | -9.2% |
| Q3 2015 | $1,880,000 | -53.0% | 57,229 | 0.0% | 0.33% | -49.2% |
| Q2 2015 | $4,002,000 | +1.1% | 57,229 | -1.0% | 0.64% | +0.8% |
| Q1 2015 | $3,960,000 | -7.4% | 57,821 | -0.9% | 0.64% | -7.4% |
| Q4 2014 | $4,275,000 | +2.5% | 58,326 | +0.3% | 0.69% | -0.6% |
| Q3 2014 | $4,172,000 | -1.0% | 58,126 | -0.2% | 0.69% | -3.7% |
| Q2 2014 | $4,213,000 | -1.3% | 58,266 | +0.4% | 0.72% | -5.0% |
| Q1 2014 | $4,270,000 | +6.6% | 58,041 | +0.8% | 0.76% | +5.1% |
| Q4 2013 | $4,005,000 | +0.4% | 57,591 | -5.1% | 0.72% | -10.5% |
| Q3 2013 | $3,988,000 | -5.9% | 60,706 | -0.7% | 0.81% | -12.1% |
| Q2 2013 | $4,236,000 | – | 61,156 | – | 0.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |